[go: up one dir, main page]

FI961339L - Triaryylieteenijohdannaiset käytettäväksi hoidossa - Google Patents

Triaryylieteenijohdannaiset käytettäväksi hoidossa Download PDF

Info

Publication number
FI961339L
FI961339L FI961339A FI961339A FI961339L FI 961339 L FI961339 L FI 961339L FI 961339 A FI961339 A FI 961339A FI 961339 A FI961339 A FI 961339A FI 961339 L FI961339 L FI 961339L
Authority
FI
Finland
Prior art keywords
therapy
triarylethylene
derivatives
triarylethylene derivatives
Prior art date
Application number
FI961339A
Other languages
English (en)
Swedish (sv)
Other versions
FI961339A0 (fi
FI961339A7 (fi
Inventor
Donald Paul Matthews
Alan Joseph Bitonti
Sickle William Anthony Van
Donald Alan Kaplan
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/259,797 external-priority patent/US5525633A/en
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI961339L publication Critical patent/FI961339L/fi
Publication of FI961339A0 publication Critical patent/FI961339A0/fi
Publication of FI961339A7 publication Critical patent/FI961339A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI961339A 1993-09-24 1994-08-19 Triaryylieteenijohdannaiset käytettäväksi hoidossa FI961339A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12661493A 1993-09-24 1993-09-24
US08/259,797 US5525633A (en) 1993-09-24 1994-06-15 Triaryl-ethylene derivatives
PCT/US1994/009314 WO1995008528A1 (en) 1993-09-24 1994-08-19 Triaryl-ethylene derivatives for use in therapy

Publications (3)

Publication Number Publication Date
FI961339L true FI961339L (fi) 1996-03-22
FI961339A0 FI961339A0 (fi) 1996-03-22
FI961339A7 FI961339A7 (fi) 1996-03-22

Family

ID=26824862

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961339A FI961339A7 (fi) 1993-09-24 1994-08-19 Triaryylieteenijohdannaiset käytettäväksi hoidossa

Country Status (17)

Country Link
US (1) US5684004A (fi)
EP (1) EP0720597B1 (fi)
JP (1) JPH09503761A (fi)
CN (1) CN1131415A (fi)
AT (1) ATE165594T1 (fi)
AU (1) AU678535B2 (fi)
CA (1) CA2171728C (fi)
DE (1) DE69409961T2 (fi)
DK (1) DK0720597T3 (fi)
ES (1) ES2115975T3 (fi)
FI (1) FI961339A7 (fi)
HU (1) HUT75933A (fi)
IL (1) IL111018A0 (fi)
NO (1) NO306292B1 (fi)
NZ (1) NZ273433A (fi)
PL (1) PL177833B1 (fi)
WO (1) WO1995008528A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099093A (en) * 1965-09-03 1968-01-17 Ici Ltd Alkene derivatives
DE2860900D1 (en) * 1977-08-22 1981-11-05 Ici Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO961204D0 (no) 1996-03-25
DE69409961D1 (de) 1998-06-04
PL313594A1 (en) 1996-07-08
PL177833B1 (pl) 2000-01-31
NO961204L (no) 1996-03-25
AU678535B2 (en) 1997-05-29
NZ273433A (en) 1997-11-24
EP0720597B1 (en) 1998-04-29
HUT75933A (en) 1997-05-28
ES2115975T3 (es) 1998-07-01
CA2171728C (en) 2001-11-13
HU9600727D0 (en) 1996-05-28
ATE165594T1 (de) 1998-05-15
FI961339A0 (fi) 1996-03-22
JPH09503761A (ja) 1997-04-15
DK0720597T3 (da) 1998-10-07
DE69409961T2 (de) 1998-09-10
US5684004A (en) 1997-11-04
CN1131415A (zh) 1996-09-18
EP0720597A1 (en) 1996-07-10
CA2171728A1 (en) 1995-03-30
AU7670794A (en) 1995-04-10
IL111018A0 (en) 1994-11-28
FI961339A7 (fi) 1996-03-22
NO306292B1 (no) 1999-10-18
WO1995008528A1 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
FI970762L (fi) Terapiassa käyttökelpoiset spiroatsabisykliset yhdisteet
NO983560D0 (no) Triazolderivater nyttige i terapi
DE69429265D1 (de) Medizinabgabe
FI960584A7 (fi) Terapeuttisia peptidijohdannaisia
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
FI962649A7 (fi) Absorptiokappale absorboivassa tuotteessa
FI962650A7 (fi) Absorboivassa tuotteessa oleva absorboiva kappale
FI943976A7 (fi) 5-aryyli-indolijohdannaiset
FI961630A7 (fi) Terapeuttisia aineita
FI944600A7 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI942444A7 (fi) Terahydropyraanijohdannaisia
FI943885L (fi) Penaami-johdannaiset
FI944044L (fi) Fenyylialkanoliamiinijohdannaiset
EE03439B1 (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
FI971193A7 (fi) Hoidossa käyttökelpoisia kinoksaliinijohdannaisia
FI956150A7 (fi) Isokinoliinijohdannaisia terapeuttisina aineina
FI961339A7 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
KR950000284U (ko) 횡연결형 장의자
KR940014624U (ko) 쑥뜸기
SE9602645D0 (sv) Azabicyclic derivatives useful in therapy
DE69400388D1 (de) Cyclohexendiolderivate
ZA9410317B (en) Substituted morpholine derivatives and their use as therapeutic agents
SE9203239D0 (sv) I l-list
DK22892D0 (da) Improvement in treatment

Legal Events

Date Code Title Description
MA Patent expired